Letter: Inhibitory effect of cholestyramine on the intestinal ulcer formation in rats given an antiphlogistic agent.
D000284:Administration, Oral; D000818:Animals; D001646:Bile / Q000378:metabolism; D002264:Carboxylic Acids / Q000008:administration & dosage; D002792:Cholestyramine Resin / Q000494:pharmacology*; D003510:Cyclohexanes / Q000008:administration & dosage; D007082:Ileum; D007192:Indenes / Q000008:administration & dosage*; D007410:Intestinal Diseases / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D051381:Rats; D014456:Ulcer / Q000139:chemically induced / Q000517:prevention & control*
D002264:Carboxylic Acids; D003510:Cyclohexanes; D007192:Indenes; D002792:Cholestyramine Resin